Mayne Pharma Group Limited (ASX: MYX)

Mayne Pharma Group Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 21, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	364	382	367	441	565	646
Market Cap Growth	4.25%	4.25%	-16.90%	-21.88%	-12.64%	-19.93%
Enterprise Value	253	264	272	717	791	942
Last Close Price	4.48	4.71	4.40	4.40	5.63	6.77
PE Ratio	-	-	3.13	-	-	-
Forward PE	-	-	-	-	-	41.76
PS Ratio	0.92	0.98	2.00	2.81	1.41	1.41
PB Ratio	0.80	0.84	0.58	0.82	0.73	0.62
P/TBV Ratio	-	-	19.16	3.46	-	5.57
P/FCF Ratio	-	-	-	-	13.52	6.24
P/OCF Ratio	-	-	-	-	9.59	5.74
PEG Ratio	0.51	0.51	0.51	0.51	0.51	0.51
EV/Sales Ratio	0.65	0.68	1.48	4.56	1.97	2.06
EV/EBITDA Ratio	11.20	14.04	-	-	15.81	14.99
EV/FCF Ratio	-10.89	-	-	-	18.94	9.09
Debt / Equity Ratio	0.09	0.09	0.07	0.77	0.45	0.39
Debt / EBITDA Ratio	1.72	1.72	-	-	6.53	5.97
Debt / FCF Ratio	-	-	-	-	8.33	3.88
Asset Turnover	0.32	0.32	0.14	0.11	0.24	0.26
Inventory Turnover	2.16	2.16	1.04	0.81	2.23	2.53
Quick Ratio	1.14	1.14	1.38	0.61	1.31	1.69
Current Ratio	1.47	1.47	1.78	0.81	1.87	2.24
Return on Equity (ROE)	-30.98%	-30.98%	-54.14%	-33.61%	-23.05%	-9.20%
Return on Assets (ROA)	-2.33%	-2.33%	-9.04%	-5.57%	-0.47%	-0.47%
Return on Capital (ROIC)	-4.74%	-4.74%	-14.03%	-7.39%	-0.60%	-0.58%
Earnings Yield	-48.90%	-45.59%	31.98%	-63.75%	-36.91%	-14.35%
FCF Yield	-6.40%	-6.08%	-13.92%	-3.90%	7.40%	16.03%
Payout Ratio	0.00%	-	38.63%	-	-	-
Buyback Yield / Dilution	3.11%	3.11%	0.15%	-4.74%	-2.75%	-3.68%
Total Shareholder Return	3.11%	3.11%	0.15%	-4.74%	-2.75%	-3.68%

Source: S&P Capital IQ. Standard template. Financial Sources.